Blog

AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5%

31 de janeiro de 2025 by

in News

AbbVie’s earnings topped estimates as it offered an upbeat view of 2025.

Relacionado

Leave a Reply Cancel reply

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.

Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.

Refresh

Best Wordpress Adblock Detecting Plugin | CHP Adblock